Clobex (clobetasol shampoo)

Clobex (clobetasol shampoo) is filed as Topical Corticosteroid. The sections below restate public label fields stored for this profile.

Class
Topical Corticosteroid
Generic name
clobetasol shampoo
Route
TOPICAL
Dosage forms
3 DOSAGE FORMS AND STRENGTHS Lotion, 0.05% w/w. Each gram of CLOBEX Lotion, 0.05%, contains 0.5 mg of clobestasol propionate in a white liquid. Lotion, 0.05% ( 3 )
Generic available
Yes
Manufacturer
Galderma Laboratories, L.P.

Approved uses

1 INDICATIONS AND USAGE CLOBEX (clobetasol propionate) Lotion, 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, in patients 18 years of age or older. ( 1.1 ). Limitations of Use: Do not use on the face, axillae or groin. ( 1.2 ) Do not use if atrophy is present at the treatment site. ( 1.2 ) Do not use for rosacea or perioral dermatitis. ( 1.2 ) 1.1 Indication CLOBEX Lotion, 0.05% is a super-high potent topical corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses only in patients 18 years of age or older. Treatment should be limited to 2 consecutive weeks. For moderate to severe plaque psoriasis, treatment may be extended for an additional 2 weeks for localized lesions (less than 10% body surface area) that have not sufficiently improved after the initial 2-week treatment. Any additional benefits of extending treatment should be weighed against the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression before prescribing for more than 2 weeks. The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week. Patients should be instructed to use CLOBEX Lotion, 0.05% for the minimum amount of time necessary to achieve the desired results [ see Dosage and Administration (2) ]. Use in patients under 18 years of age is not recommended due to numerically high rates of HPA axis suppression [ see Warnings and Precautions (5.1) and Use in Specific Populations (8.4) ]. 1.2 Limitations of Use CLOBEX Lotion, 0.05% should not be used on the face, axillae, or groin and should not be used if there is atrophy at the treatment site. CLOBEX Lotion, 0.05% should not be used in the treatment of rosacea or perioral dermatitis.

How it works

Like other topical corticosteroids, CLOBEX (clobetasol propionate) Shampoo, 0.05%, has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A 2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A 2 .

Contraindications

4 CONTRAINDICATIONS None None. ( 4 )

Adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions (incidence > 1%) are skin atrophy, telangiectasia, discomfort skin and skin dry. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Galderma Laboratories, L.P. at 1-866-735-4137 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In controlled, clinical trials with CLOBEX Lotion, 0.05%, the following adverse reactions have been reported: burning/stinging, skin dryness, irritation, erythema, folliculitis, pruritus, skin atrophy, and telangiectasia. The pooled incidence of local adverse reactions in trials for psoriasis and atopic dermatitis with CLOBEX Lotion, 0.05% at 1% or greater was: Table 1: Adverse Reactions with Incidence ≥ 1% in Clinical Trials Adverse Reaction Incidence Skin Atrophy 4.2% Telangiectasia 3.2% Discomfort Skin 1.3% Skin Dry 1.0% Most local adverse events were rated as mild to moderate and they are not affected by age, race or gender. Systemic absorption of topical corticosteroids has produced hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. 6.2 Postmarketing Experience Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The following adverse reactions have been identified during post-approval use of CLOBEX Lotion, 0.05%. Endocrine disorders: Cushing’s syndrome, Adrenal suppression Skin: Rash, Pain of skin, Skin exfoliation, Skin chapped, Scaling, Induration/papulation, Lichenification. Other: Psoriasis (aggravation), Plaque Elevation, Excoriation.

Dosage and administration

CLOBEX Shampoo, 0.05% is for topical use only, and not for ophthalmic, oral or intravaginal use. CLOBEX Shampoo, 0.05%, should be applied onto dry (not wet) scalp once a day in a thin film to the affected areas only, and left in place for 15 minutes before lathering and rinsing. The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week. Move the hair away from the scalp so that one of the affected areas is exposed. Position the bottle over the lesion. Apply a small amount of the shampoo directly onto the lesion, letting the product naturally flow from the bottle (gently squeeze the bottle), avoiding any contact of the product with the facial skin, eyes or lips. In case of contact, rinse thoroughly with water. Spread the product so that the entire lesion is covered with a thin uniform film. Massage gently into the lesion and repeat for additional lesion(s). Wash your hands after applying CLOBEX Shampoo, 0.05%. Leave the shampoo in place for 15 minutes, then add water, lather and rinse thoroughly all parts of the scalp and body that came in contact with the shampoo (e.g., hands, face, neck and shoulders). Avoid contact with eyes and lips. Minimize contact to non-affected areas of the body. Although no additional shampoo is necessary to cleanse your hair, you may use a non-medicated shampoo if desired. Treatment should be limited to 4 consecutive weeks. As with other corticosteroids, therapy should be discontinued when control is achieved. If complete disease control is not achieved after 4 weeks of treatment with CLOBEX Shampoo, 0.05%, treatment with a less potent topical steroid may be substituted. If no improvement is seen within 4 weeks, reassessment of the diagnosis may be necessary. CLOBEX Shampoo, 0.05%, should not be used with occlusive dressings (shower cap or bathing cap) unless directed by a physician.

Common questions

What is Clobex approved to treat?

According to its FDA label, Clobex (clobetasol shampoo) is approved for: 1 INDICATIONS AND USAGE CLOBEX (clobetasol propionate) Lotion, 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, in patients 18 years of age or older. ( 1.1 ). Limitations of Use: Do not use… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Clobex?

Clobex (clobetasol shampoo) belongs to the Topical Corticosteroid class of medications.

What form does Clobex come in?

The FDA label lists Clobex (clobetasol shampoo) as: 3 DOSAGE FORMS AND STRENGTHS Lotion, 0.05% w/w. Each gram of CLOBEX Lotion, 0.05%, contains 0.5 mg of clobestasol propionate in a white liquid. Lotion, 0.05% ( 3 ); topical route. Available strengths and packaging vary by manufacturer.

Is there a generic version of Clobex?

Yes. A generic version of Clobex (clobetasol shampoo) is available in the U.S. Ask your pharmacist about substitution.

Does Clobex have a Boxed Warning?

Our ingest of the FDA label for Clobex (clobetasol shampoo) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does Clobex cost?

Public CMS NADAC pricing for Clobex (clobetasol shampoo) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Clobex currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Clobex (clobetasol shampoo) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Clobex approved by the FDA?

The FDA record lists the approval date for Clobex (clobetasol shampoo) as 2003-07-24.

Who makes Clobex?

The FDA label lists Galderma Laboratories, L.P. as a labeler/manufacturer of Clobex (clobetasol shampoo). Multiple firms may market generics of the same molecule.

How should Clobex be stored?

The FDA label states: "CLOBEX Shampoo, 0.05%, is a translucent, colorless to pale yellow viscous liquid, supplied in 4 fl. oz. (118 mL) bottles. NDC 0299-3847-04 Storage: Keep tightly closed. Store at USP controlled room temperature 68˚ to 77˚…" Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…